Yali Friedman – Page 12

Patenting the Microbiome

This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post? […]

This is a guest post from Michael D. Hooven, President & CEO, Enable Injections Inc. The oxpecker perches on the backs

This is a guest post from Craig Stropkay. Craig is Director and Life Science Consultant at KOLgroups, LLC Reach for the

These are relative terms. If I license a product from you, I am in-licensing it and you are out-licensing it.

This is a guest post from Steve Kirsh. Steve is Founder + Managing Partner of Khameleon Group. When was the

This is a guest post from Avneet Heer, a student in the MS Biotechnology BioBusiness Track at Georgetown University. Do

How do biotech venture investments in public equities (known as VIPEs) perform? Do they outperform mutual funds and hedge funds?

How do biotech stocks behave during the first day of trading? How do they perform in the long-run period? What

After months of development and feedback from customers, DrugPatentWatch is proud to announce the availability of two new datasets: Bulk

This is a guest post from Mark D. Shtilerman1 and Joseph Eng Jr. Dr. Shtilerman is Senior Counsel at Deerfield